.jpg)
The company has been reported to be retrenching staff.
'No matter how much the political pressure is, I cannot say I will bring the Moon for you tomorrow!'
Nestle was perceived as being feeble in its defence.
A global policy would reward firms which strive for higher quality.
The finance ministry has issued a note which says that the government and the RBI's move to take out Rs 500 and Rs 1,000 banknotes from circulation will help India towards cash-less economy where most transactions are done electronically and that can be tracked.
News of all that's transpired on and off the football field.
In fresh troubles for Nestle over safety standards of its famous Maggi noodle brand, the Uttrakhand Food Safety Department has collected samples of the 'two-minute' noodles from the company's Pantanagar plant and other places in the state.
Leading pharmaceutical firms such as Cipla and Ranbaxy are among the firms pulled up by the drug price regulator National Pharmaceuticals Pricing Authority (NPPA) for overcharging.
If pandemic (mis)management threatened to dominate Goa's electoral discourse, the BJP is up against a deeper structural issue in its organisation, created by the fact that a majority of the legislature party and the ministerial council is made up of Congress defectors, disparagingly referred to by the Opposition as "imports". Radhika Ramaseshan reports.
Broader market underperformed the headline indices with BSE Midcap and BSE Smallcap finishing in red
The payment of Kremlin grants will cease the month after anti-doping authorities find an athlete, coach or sports specialist guilty of involvement in the use of performance- enhancing drugs, Putin's decree said.
'There was no fight between the Shiv Sena and her.' 'But if she is still targeting the Shiv Sena, then only she can talk about the reason behind it.'
CBD oil, found in marijuana, is gaining popularity for its pain-relieving properties. It's now legally available in India
.jpg)
The company had in May announced that the US Food and Drug Administration had issued an import alert on its Waluj facility, which makes injectables and solid dosages.
The approval comes a day after Sinopharm said its vaccine showed 79.34 per cent efficacy and a 99.52 per cent antibody-positive conversion rate in the interim results of the Phase III clinical trials.
Chinese Olympic women's swimmer Chen Xinyi tested positive for a banned substance at the Rio Olympics on August 7, state media said on Friday citing the country's swimming association, the latest doping scandal to mar competition at the Games.
India's antitrust regulator has approved Sun-Ranbaxy deal, subject to the companies divesting seven products.
Delhi Chief Minister and AAP National Convener Arvind Kejriwal unveiled the party's manifesto for the youth. The party, which is aiming to capture power in the state, will come out with separate manifestos for different sections of society.
Drug maker Marksans Pharma on Thursday said it has acquired UK-based generic pharmaceutical company Relonchem for an undisclosed amount.
The law bans fruit and spice-flavoured cigarettes, slaps expansive new warnings on packages and gets rid of the monikers 'light' and 'low-tar'.
Among other things, taking note of complaints against several Chinese e-commerce players such as Shein, Ali Express etc for sending shipments as 'gifts' to customers in India and avoiding duties, the government has now mandated that all e-commerce sites and apps must have a registered business entity. This will be the importer on record and subject to customs rules, report Subhayan Chakraborty, Neha Alawadhi and Karan Choudhury.
Nestl India is preparing a blueprint for a possible relaunch.
Glenmark Generics Inc USA, the subsidiary of Glenmark Generics Ltd has received nod for it's Hydrocortisone Butyrate Cream USP (0.1 per cent), abbreviated new drug approval from the United States Food and Drug Administration, Glenmark Pharmaceuticals said in a statement.
US President Barack Obama has signed a historic bill that gives the government powers to curb advertising and promotion of tobacco products.
Japanese drug major Daiichi Sankyo on Saturday deferred its proposed open offer to acquire an additional 20 per cent stake in Ranbaxy Laboratories, citing a delay in approvals from market regulator Securities & Exchange Board of India.
CCI is India's competition regulator. The undertaking will be a part of the CCI's proposed 'competition compliance' programme.
India has asked Indonesia to remove barriers on import of pharma products, in a bid to boost trade ties between the two countries.
The implementation of the policy would require public health spending to rise to nearly 2.5 per cent of the gross domestic product, from the present dismal one per cent, with the Centre bearing about 40 per cent of it.
In a move likely to influence future drug price regulation in the country, the National Pharmaceutical Pricing Authority (NPPA) has started a process to understand how other countries carry out this function.The authority has already studied the relevant regulatory systems in at least eight major countries. It has also finalised a round-table meeting on April 11 in New Delhi to sensitise stakeholders on the need to have an international outlook.
'I would recommend two parts to fiscal support. One, support the lower end of the society by direct intervention through ways such as direct benefit cash transfer. Second, give fiscal support to the stressed sectors in line with the Rs 3-lakh crore (Rs 3 trillion) emergency credit line guarantee norms'
Last week, after months of scrutiny, the Forward Markets Commission, the regulator for futures trading in commodities, approved a proposal from state-owned MMTC Ltd and finance-to-real estate group Indiabulls to set up a national multi-commodity exchange.
Glaxo Group 'neglected the duty of making timely disclosures' to the stock exchanges the BSE and the NSE, on various occasions, the Securities and Exchange Board of India said in its order.
The APG released its much-awaited 228-page 'Mutual Evaluation Report' on Saturday, 10 days ahead of the key Financial Action Task Force's plenary meeting which will give its decision on Pakistan's 'grey list' status.
A widening probe by US authorities involving top drug companies following complaints of price fixing of generics was a point of worry for the participants, said analysts.
The United States 'is leading the world in the use of compulsory licenses, and is hypocritical in voicing indignance when developing countries issue compulsory licenses for essential drugs,' Washington-based Knowledge Ecology International, with its offices in Geneva, has alleged.
Ministerial consultations on, with recognition of the potential, and the need to not classify it under the same rules as for pharmaceuticals.
It is the most potent symbol of India's soft power -- more perhaps than the IT industry and our managerial skill, notes Vanita Kohli-Khandekar
India's largest biotechnology company Biocon is planning to tap the potential of biosimilars (generics or copycat versions of biotech drugs going off patent) in the regulated markets of the US and Europe, besides taking Insugen, its own version of insulin, to the global markets in a big way.
The stock was the worst hit among the blue-chips on both BSE and NSE.
The BSE Midcap also cut all its intraday gains to shed 0.3% at close
